Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
CJC-1295 (no DAC) + Ipamorelin Dual Peptide Blend (GHRH Analog + GHSR Agonist) Compound Name: CJC-1295 (no DAC) + Ipamorelin Classification: Research Peptides GHRH Analog + Growth Hormone Secretagogue Description: This research blend contains two laboratory peptides: CJC-1295 (no DAC) a modified growth hormonereleasing hormone (GHRH) analog Ipamorelin a selective growth hormone secretagogue receptor (GHSR) agonist Together, these compounds are widely studied in controlled research environments for their involvement in growth-hormonerelated signaling pathways, endocrine regulation, and peptide-mediated biological activity
DSIP Timeline & What to Monitor Older trials measured sleep architecture changes within the first or second night of dosing, using polysomnography
Luxury Wellness
On July 23-24, 2026 , the FDA's Pharmacy Compounding Advisory Committee (PCAC) will convene at the FDA White Oak Campus (10903 New Hampshire Avenue, Silver Spring, MD 20993) to evaluate whether several peptides should be added to the Section 503A bulk drug substances list
One-step cellular caspase-3/7 assay
BPC-157 is supplied as lyophilized powder for stability during storage and transport
US$ 28.17
US$ 22.77
US$ 29.62
US$ 20.27
